DCF — ST. JOSEPHS REG MED CENTER S. BEND
Enterprise Value: $-419.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-419.9M
Enterprise Value
$-136.3M
PV of Cash Flows
$-283.6M
PV of Terminal Value
$-456.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $365.8M | $-24.3M | -7.0% | $-39.7M | $-36.1M |
| Year 2 | $376.7M | $-21.2M | -6.0% | $-37.2M | $-30.7M |
| Year 3 | $388.0M | $-18.0M | -5.0% | $-34.4M | $-25.9M |
| Year 4 | $399.7M | $-16.5M | -4.0% | $-33.4M | $-22.8M |
| Year 5 | $411.7M | $-16.0M | -4.0% | $-33.4M | $-20.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-419.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$355.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07134202596672018
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5